HOME >> MEDICINE >> NEWS
FDA approves Baxters ADVATE for the treatment of hemophilia A

Deerfield, Ill., July 25, 2003 -- Baxter Healthcare Corporation announced today that the U.S. Food and Drug Administration (FDA) has approved ADVATE (Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method) rAHF-PFM for the prevention and control of bleeding episodes in people with hemophilia A. ADVATE is the first and only factor VIII made without any added human or animal plasma proteins and albumin in the cell culture process, purification and final formulation, thereby eliminating the risk of infections caused by viruses that may be carried in these proteins.

Developed by Baxter through its innovative technology and many years in hemophilia research, ADVATE is a genetically engineered, or recombinant, full-length clotting factor VIII that is similar to the natural clotting factor found in a healthy body. The new technology used to prepare ADVATE which is the most advanced factor VIII treatment for hemophilia to date eliminates the addition of human and animal plasma proteins and albumin to provide unsurpassed pathogen safety, while maintaining the proven efficacy of the full-length RECOMBINATE rAHF molecule, the current leader for hemophilia A therapy.

"It's widely recognized by the hemophilia community that there is a need to provide patients with treatments that eliminate the risk for infection. While treatment options to date have provided effective disease management, there has been an acknowledged, lingering concern about the potential for viral transmission with these therapies," said Michael Tarantino, M.D., associate professor of Pediatrics at the University of Illinois and medical director of the Comprehensive Bleeding Disorder Center in Peoria, Ill. "ADVATE is the first therapy to meet this need for safety, virtually eliminating the risk of transmission of human pathogens."

Other genetically engineered factor VIII therapies use human plasma protein solutions and/or other human- or animal-derived materials during proce
'"/>

Contact: Cindy Resman, BAXTER
847-948-2815
Porter Novelli
28-Jul-2003


Page: 1 2 3 4 5 6

Related medicine news :

1. FDA approves Pfizers Lyrica for the treatment of the two most common forms of neuropathic pain
2. FDA approves Enablex for treatment of overactive bladder
3. FDA approves Fosrenol(R) in end-stage renal disease (ESRD) patients
4. FDA approves Adderall XR (R) to treat ADHD in adults
5. FDA approves EPZICOM
6. FDA approves new labelling for Seroquel in bioplar mania
7. FDA approves Enbrel to treat psoriasis
8. FDA approves Climara Pro to treat menopause symptoms
9. FDA approves new approach to schizophrenia treatment
10. FDA approves new HIV protease inhibitor, Lexiva (TM)
11. FDA approves Wellbutrin XL(TM)

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... August 05, 2020 , ... The Veterinary Cooperative ... of the largest veterinarian-owned purchasing Cooperative in the United States. , Hamele has ... she gained extensive knowledge and experience in the animal health industry. In her ...
(Date:8/5/2020)... WASHINGTON (PRWEB) , ... August 04, 2020 , ... Today, ... Maternal and Child Health Programs (AMCHP) with the 2020 Innovation Station Best Practice Award. ... if, when and under what circumstances to get pregnant and have a child. One ...
(Date:7/31/2020)... ... 2020 , ... Leaders of the Operation Warp Speed ... Savannah, GA. Visitors included Moncef Slaoui, chief advisor, and General Gustave F. Perna, ... OWS program to accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, ...
(Date:7/22/2020)... ... ... of August’s Children’s Eye Health and Safety Month, and as a follow-up to its 2016 ... has released an updated version of the report titled Children’s Vision and Eye ... is , to provide updated surveillance data, , ...
(Date:7/18/2020)... ... , ... A June 2 article on Daily Mail reported on a fitness model ... augmentations. The article says that her first procedure, unbeknownst to her, was performed by a ... surgeon to revise her procedure, only to find out the doctor did not have the ...
Breaking Medicine News(10 mins):
(Date:8/5/2020)... ... August 04, 2020 , ... Fifty six percent of older adults think ... effectively to a healthcare crisis like COVID-19, according to a new survey by The ... important issues for older voters this year,” says Mary Johnson, a Medicare, and Social ...
(Date:8/3/2020)... SEATTLE (PRWEB) , ... August 03, 2020 , ... ... announced that an agreement has been reached, to amend and restate IDRI’s license ... of the United States and Canada). Under the amendment, the parties have agreed ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... What is the purpose of sleep? Most ... with a more detailed response? Other than when we feel sick or tired from a ... us don’t really jump to accusing our poor sleeping habits or our own daily choices ...
Breaking Medicine Technology:
Cached News: